<DOC>
	<DOCNO>NCT01487421</DOCNO>
	<brief_summary>This study conduct Europe . The aim study investigate potential supplementary insulin therapy regimen ( SIT ) intensification insufficiently control patient type 2 diabetes normal diabetes care set .</brief_summary>
	<brief_title>An Observational Study Insulin Aspart , Necessary , Insulin Levemir ( FlexPenÂ® ) Evening Bedtime</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<criteria>Type 2 diabetes OAD monotherapy OAD combination therapy Therapy OAD basal insulin Conventional insulin therapy premixed insulin</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>